Bisquaternary oximes as reactivators of tabun-inhibited human brain cholinesterases: An in vitro study

Basic and Clinical Pharmacology and Toxicology

Volumn 101, Issue 1, 2007, Pages 25-28

  Kuca, Kamil ^a,b   Jun, Daniel ^a,b   Cabal, Jiri ^b   Musilova, Lucie ^c  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; CHOLINESTERASE REACTIVATOR; K 027; K 033; K 048; OBIDOXIME; OXIME DERIVATIVE; TABUN; TRIMEDOXIME; UNCLASSIFIED DRUG;

ARTICLE; BRAIN; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVATION; HOMOGENATE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

BRAIN; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; HUMANS; OXIMES; PHOSPHORIC ACID ESTERS; PYRIDINIUM COMPOUNDS;

RATTUS;

EID: 34250624979     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00085.x     Document Type: Article

References (27)

1. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004 38: 151 216.
2. Marrs TC. Organophosphate poisoning. Pharmacol Ther 1993 58: 51 66.
3. Kuca K, Jun D, Musilek K. Structural requirements of acetylcholinesterase reactivators. Mini Rev Med Chem 2006 6: 269 77.
4. Eto M. Organophosphorus pesticides: organic and biological chemistry. CRC Press Inc., Cleveland 1976 142.
5. Koplovitz I, Menton R, Matthews C, Shutz M, Nalls C, Kelly S. Dose-response effects of atropine and HI-6 treatment of organophosphorus poisoning in guinea pigs. Drug Chem Toxicol 1995 18: 119 36.
6. Ekstrom F, Akfur C, Tunemalm AK, Lundberg S. Structural changes of phenylalanine 338 and histidine 447. Biochemistry 2006 45: 74 81.
7. Cabal J, Kuca K, Kassa J. Specification of the structure of oximes able to reactivate tabun inhibited acetylcholinesterase. Basic Clin Pharmacol Toxicol 2004 95: 81 6.
8. Calic M, Lucic-Vrdoljak A, Radic B et al. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 2006 219: 85 96.
9. Kuca K, Cabal J, Jun D, Hrabinova M. In vitro evaluation of acetylcholinesterase reactivators as potential antidotes against tabun nerve agent poisonings. Drug Chem Toxicol 2006 29: 443 9.
10. Kuca K, Bielavsky J, Cabal J, Bielavska M. Synthesis of a potential reactivator of acetylcholinesterase 1-(4-hydroxyiminomethylpyridinium)-3- (carbamoylpyridinium)-propane dibromide. Tetrahedron Lett 2003 44 3123 5.
11. Kuca K, Bielavsky J, Cabal J, Kassa J. Synthesis of a new reactivator of tabun inhibited acetylcholinesterase. Bioorg Med Chem Lett 2003 13: 3545 7.
12. Kuca K, Kassa J. A comparison of the ability of a new bispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J Enzyme Inhib Med Chem 2003 18: 529 35.
13. Kuca K, Kassa J. In vitro reactivation of acetylcholinesterase using of the oxime K027. Vet Hum Toxicol 2004 46: 15 8.
14. Kassa J, Kuca K, Cabal J, Paar M. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vitro and in vivo methods. J Toxicol Environ Health 2006 69: 1875 82.
15. Kuca K, Cabal J, Patocka J, Kassa J. Synthesis of bisquaternary symmetric - χ,δ-bis(2-hydroxyiminomethylpyridinium)alkane dibromides and their reactivation of cyclosarin-inhibited acetylcholinesterase. Lett Org Chem 2004 1: 84 6.
16. Musilek K, Holas O, Hambalek J et al. Synthesis of bispyridinium compounds bearing propane linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. Lett Org Chem 2006 3: 831 5.
17. Musilek K, Lipka L, Racakova V et al. New methods in synthesis of acetylcholinesterase reactivators and evaluation of their potency to reactivate cyclosarin-inhibited AChE. Chem Pap 2006 60: 48 51.
18. Palecek J, Cirkva V, Relich S, Slavetinska L, Kuca K, Jun D. Assignment of organophosphorus-inhibited acetylcholinesterase reactivators structures on the basis of nuclear magnetic resonance spectra. Zprav Voj Farm 2005 15: 14 25 (in Czech).
19. Kuca K, Jun D, Cabal J, Hrabinova M, Bartosova L, Opletalova V. Russian VX: inhibition and reactivation of acetylcholinesterase and its comparison with VX-agent. Basic Clin Pharmacol Toxicol 2006 98: 389 94.
20. Bajgar J, Fusek J, Kuca K, Bartosova L, Jun D. Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. Mini Rev Med Chem 2007 7: 461 6.
21. Sevelova L, Kuca K, Krejcova G. Antidotal treatment of GF-agent intoxication in mice with new bispyridinium oximes. Toxicology 2005 207: 1 6.
22. Puu G, Artursson E, Bucht G. Reactivation of nerve agent inhibited acetylcholinesterases by HI-6 and obidoxime. Biochem Pharmacol 1986 35: 1505 10.
23. Clement JG, Shiloff JD, Gennings J. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning in mice. Arch Toxicol 1987 61: 70 5.
24. Clement JG. HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat. Biochem Pharmacol 1982 31: 1283 9.
25. Kuca K, Cabal J, Kassa J. In vitro reactivation of sarin-inhibited brain acetylcholinesterase from various species by various oximes. J Enzyme Inhib Med Chem 2005 20: 227 32.
26. Worek F, Reiter G, Eyer P, Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol 2002 76: 523 9.
27. Kuca K, Patocka J, Cabal J. Reactivation of organophosphate inhibited acetylcholinesterase activity by α,ω-bis-(4- hydroxyiminomethylpyridinium)alkanes in vitro. J Appl Biomed 2003 1: 207 11.